|
|
Blood, 15 May 2006, Vol. 107, No. 10, pp. 4189-4193.
Prepublished online as a Blood First Edition Paper on January 19, 2006; DOI 10.1182/blood-2005-09-3741.
Previous Article | Next Article 
Submitted September 19, 2005
Accepted January 6, 2006
Prognostic significance of NOD2/CARD15 variants in HLA-identical sibling hematopoietic stem cell transplantation: Effect on long term outcome is confirmed in 2 independent cohorts and may be modulated by the type of gastrointestinal decontamination
Ernst Holler*, Gerhard Rogler, Julia Brenmoehl, Joachim Hahn, Hans Herfarth, Hildegard Greinix, A M Dickinson, G Socie, D Wolff, G Fischer, G Jackson, V Rocha, B Steiner, G Eissner, J Marienhagen, J Schoelmerich, and R Andreesen
Department of Haematology/Oncology, University of Regensburg, Regensburg, Germany
Department of Internal Medicine I, University of Regensburg, Regensburg, Germany
Department of Internal Medicine I, Medical University of Vienna, Vienna, Austria
School of Laboratory and Clinical Sciences, University of Newcastle upon Tyne, Newcastle, United Kingdom
HSCT Unit, Hopital St. Louis, Paris, France
Department of Haematology and Oncology, University of Rostock, Rostock, Germany
Department of Blood Group Serology, Medical University of Vienna, Vienna, Germany
Centre for Clinical Trials, University of Regensburg, Regensburg, Germany
* Corresponding author; email: ernst.holler{at}klinik.uni-regensburg.de.
In order to assess the role of NOD2/CARD15 variants on the long term outcome of allogeneic stem cell transplantation in a genetically homogenous group, we extended our previous study (cohort I, n=78) and typed DNA from additional 225 recipients and their HLA-identical sibling donors (cohort II) from 4 European centres for NOD2/CARD15 SNPs. Results of genotyping were compared with clinical outcome: The strong association of NOD2/CARD15 variants with transplant related mortality (TRM) was confirmed in univariate and multivariate analysis: TRM increased from 20% in cohort I/ 22% in cohort II in recipient/donor pairs without any NOD2/CARD15 variants to 47% (cohort I)/ 32% (cohort II) in the presence of 1 variant in either donor or recipient and further to 57% (cohort I) / 74% (cohort II) in the presence of 2 or more variants (p 0.002 in both cohorts). NOD2/CARD15 SNPs were not associated with relapse rate but had a strong impact on overall survival. In an analysis of centre effects, the type of gastrointestinal decontamination was the only factor interfering with the prognostic significance of NOD2/CARD15 SNPs. Our data further support an interaction between gastrointestinal defense mechanisms, activation of the innate immune system and specific transplant related complications.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
G. Socie and B. R. Blazar
Acute graft-versus-host disease: from the bench to the bedside
Blood,
November 12, 2009;
114(20):
4327 - 4336.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. L. Espinoza, A. Takami, M. Onizuka, H. Sao, H. Akiyama, K. Miyamura, S. Okamoto, M. Inoue, Y. Kanda, S. Ohtake, et al.
NKG2D gene polymorphism has a significant impact on transplant outcomes after HLA-fully-matched unrelated bone marrow transplantation for standard risk hematologic malignancies
Haematologica,
October 1, 2009;
94(10):
1427 - 1434.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
O. Penack, O. M. Smith, A. Cunningham-Bussel, X. Liu, U. Rao, N. Yim, I.-K. Na, A. M. Holland, A. Ghosh, S. X. Lu, et al.
NOD2 regulates hematopoietic cell function during graft-versus-host disease
J. Exp. Med.,
September 28, 2009;
206(10):
2101 - 2110.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Hauser, O. Zach, O. Krieger, H. Kasparu, J. Koenig, M. Girschikofsky, R. Oberbauer, and D. Lutz
A single nucleotide polymorphism at chromosome 2q21.3 (LCT -13910C>T) associates with clinical outcome after allogeneic hematopoietic stem cell transplantation
Blood,
September 1, 2008;
112(5):
2156 - 2159.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Holler, J. Hahn, R. Andreesen, G. Rogler, J. Brenmoehl, H. Greinix, A. M. Dickinson, G. Socie, D. Wolff, and J. Finke
NOD2/CARD15 Polymorphisms in Allogeneic Stem-Cell Transplantation From Unrelated Donors: T Depletion Matters
J. Clin. Oncol.,
January 10, 2008;
26(2):
338 - 339.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. P. Mayor, B. E. Shaw, D. A. Hughes, H. Maldonado-Torres, J. A. Madrigal, S. Keshav, and S. G.E. Marsh
In Reply
J. Clin. Oncol.,
January 10, 2008;
26(2):
339 - 339.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. P. Mayor, B. E. Shaw, D. A. Hughes, H. Maldonado-Torres, J. A. Madrigal, S. Keshav, and S. G.E. Marsh
Single Nucleotide Polymorphisms in the NOD2/CARD15 Gene Are Associated With an Increased Risk of Relapse and Death for Patients With Acute Leukemia After Hematopoietic Stem-Cell Transplantation With Unrelated Donors
J. Clin. Oncol.,
September 20, 2007;
25(27):
4262 - 4269.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K.-H. Lee, S. S. Park, I. Kim, J. H. Kim, E. K. Ra, S.-S. Yoon, Y.-C. Hong, S. Park, and B. K. Kim
P2X7 receptor polymorphism and clinical outcomes in HLA-matched sibling allogeneic hematopoietic stem cell transplantation
Haematologica,
May 1, 2007;
92(5):
651 - 657.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Mullally and J. Ritz
Beyond HLA: the significance of genomic variation for allogeneic hematopoietic stem cell transplantation
Blood,
February 15, 2007;
109(4):
1355 - 1362.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Holowiecka-Goral, J. Wojnar, S. Giebel, E. Grudziecka, M. Oczko, B. Jarzab, and M. Sankowska
SNP12 and SNP13 Variants of NOD2/CARD15 Gene of Donor and Recipient as Independent Risk Factors for Severe Intestinal and Pulmonary GVHD after Allogeneic Hematopoietic Stem Cell Transplantation.
Blood (ASH Annual Meeting Abstracts),
November 16, 2006;
108(11):
3242 - 3242.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Franchi, C. McDonald, T.-D. Kanneganti, A. Amer, and G. Nunez
Nucleotide-Binding Oligomerization Domain-Like Receptors: Intracellular Pattern Recognition Molecules for Pathogen Detection and Host Defense
J. Immunol.,
September 15, 2006;
177(6):
3507 - 3513.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|